Despite the availability of a cheap and effective treatment, tuberculosis still accounts for millions of cases of active disease and deaths worldwide. The disease disproportionately affects the poorest persons in both high-income and developing countries.1 However, recent advances in diagnostics, drugs, and vaccines and enhanced implementation of existing interventions have increased the prospects for improved clinical care and global tuberculosis control.
Tuberculosis / A. Zumla, M. Raviglione, R. Hafner, C. Fordham von Reyn. - In: NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 368:8(2013), pp. 745-755.
Tuberculosis
M. Raviglione;
2013
Abstract
Despite the availability of a cheap and effective treatment, tuberculosis still accounts for millions of cases of active disease and deaths worldwide. The disease disproportionately affects the poorest persons in both high-income and developing countries.1 However, recent advances in diagnostics, drugs, and vaccines and enhanced implementation of existing interventions have increased the prospects for improved clinical care and global tuberculosis control.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
nejmra1200894.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
677.46 kB
Formato
Adobe PDF
|
677.46 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
